251 related articles for article (PubMed ID: 20188563)
1. Extracellular BMP-antagonist regulation in development and disease: tied up in knots.
Walsh DW; Godson C; Brazil DP; Martin F
Trends Cell Biol; 2010 May; 20(5):244-56. PubMed ID: 20188563
[TBL] [Abstract][Full Text] [Related]
2. Virtual screening and selection of drug-like compounds to block noggin interaction with bone morphogenetic proteins.
Ahmed S; Metpally RP; Sangadala S; Reddy BV
J Mol Graph Model; 2010 Apr; 28(7):670-82. PubMed ID: 20137990
[TBL] [Abstract][Full Text] [Related]
3. Bone morphogenetic proteins in bone stimulate osteoclasts and osteoblasts during bone development.
Okamoto M; Murai J; Yoshikawa H; Tsumaki N
J Bone Miner Res; 2006 Jul; 21(7):1022-33. PubMed ID: 16813523
[TBL] [Abstract][Full Text] [Related]
4. Potential drug targets within bone morphogenetic protein signaling pathways.
Gazzerro E; Minetti C
Curr Opin Pharmacol; 2007 Jun; 7(3):325-33. PubMed ID: 17475557
[TBL] [Abstract][Full Text] [Related]
5. BMP antagonists: their roles in development and involvement in pathophysiology.
Yanagita M
Cytokine Growth Factor Rev; 2005 Jun; 16(3):309-17. PubMed ID: 15951218
[TBL] [Abstract][Full Text] [Related]
6. BMP modulators regulate the function of BMP during body patterning and disease progression.
Yanagita M
Biofactors; 2009; 35(2):113-9. PubMed ID: 19449438
[TBL] [Abstract][Full Text] [Related]
7. Bone morphogenetic protein (BMP)-6 signaling and BMP antagonist noggin in prostate cancer.
Haudenschild DR; Palmer SM; Moseley TA; You Z; Reddi AH
Cancer Res; 2004 Nov; 64(22):8276-84. PubMed ID: 15548695
[TBL] [Abstract][Full Text] [Related]
8. The RING domain of PIASy is involved in the suppression of bone morphogenetic protein-signaling pathway.
Imoto S; Sugiyama K; Yamamoto T; Matsuda T
Biochem Biophys Res Commun; 2004 Jun; 319(1):275-82. PubMed ID: 15158472
[TBL] [Abstract][Full Text] [Related]
9. BMP receptor signaling: transcriptional targets, regulation of signals, and signaling cross-talk.
Miyazono K; Maeda S; Imamura T
Cytokine Growth Factor Rev; 2005 Jun; 16(3):251-63. PubMed ID: 15871923
[TBL] [Abstract][Full Text] [Related]
10. Deletion mutants of BMP folding variants act as BMP antagonists and are efficient inhibitors for heterotopic ossification.
Weber FE; Schmökel H; Oelgeschläger M; Nickel J; Maly FE; Hortschansky P; Grätz KW
J Bone Miner Res; 2003 Dec; 18(12):2142-51. PubMed ID: 14672349
[TBL] [Abstract][Full Text] [Related]
11. Antagonists of bone morphogenetic proteins in kidney disease.
Yanagita M
Curr Opin Investig Drugs; 2010 Mar; 11(3):315-22. PubMed ID: 20178045
[TBL] [Abstract][Full Text] [Related]
12. BMP signaling regulates PGC numbers and motility in organ culture.
Dudley BM; Runyan C; Takeuchi Y; Schaible K; Molyneaux K
Mech Dev; 2007 Jan; 124(1):68-77. PubMed ID: 17112707
[TBL] [Abstract][Full Text] [Related]
13. BMP signaling in skeletal development.
Wan M; Cao X
Biochem Biophys Res Commun; 2005 Mar; 328(3):651-7. PubMed ID: 15694398
[TBL] [Abstract][Full Text] [Related]
14. Bone morphogenetic protein signaling in the developing kidney: present and future.
Cain JE; Hartwig S; Bertram JF; Rosenblum ND
Differentiation; 2008 Oct; 76(8):831-42. PubMed ID: 18331343
[TBL] [Abstract][Full Text] [Related]
15. Wnt/beta-catenin signaling regulates expression of PRDC, an antagonist of the BMP-4 signaling pathway.
Im J; Kim H; Kim S; Jho EH
Biochem Biophys Res Commun; 2007 Mar; 354(1):296-301. PubMed ID: 17222801
[TBL] [Abstract][Full Text] [Related]
16. Bone morphogenetic protein signaling inhibits hair follicle anagen induction by restricting epithelial stem/progenitor cell activation and expansion.
Zhang J; He XC; Tong WG; Johnson T; Wiedemann LM; Mishina Y; Feng JQ; Li L
Stem Cells; 2006 Dec; 24(12):2826-39. PubMed ID: 16960130
[TBL] [Abstract][Full Text] [Related]
17. Bone morphogenetic protein-9 induces apoptosis in prostate cancer cells, the role of prostate apoptosis response-4.
Ye L; Kynaston H; Jiang WG
Mol Cancer Res; 2008 Oct; 6(10):1594-606. PubMed ID: 18922975
[TBL] [Abstract][Full Text] [Related]
18. BMP signalling: agony and antagony in the family.
Brazil DP; Church RH; Surae S; Godson C; Martin F
Trends Cell Biol; 2015 May; 25(5):249-64. PubMed ID: 25592806
[TBL] [Abstract][Full Text] [Related]
19. Secreted BMP antagonists and their role in cancer and bone metastases.
Todd GM; Gao Z; Hyvönen M; Brazil DP; Ten Dijke P
Bone; 2020 Aug; 137():115455. PubMed ID: 32473315
[TBL] [Abstract][Full Text] [Related]
20. Bmp modulators in kidney disease.
Nakamura J; Yanagita M
Discov Med; 2012 Jan; 13(68):57-63. PubMed ID: 22284784
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
